304 related articles for article (PubMed ID: 24768741)
1. Genetic variants and animal models in SNCA and Parkinson disease.
Deng H; Yuan L
Ageing Res Rev; 2014 May; 15():161-76. PubMed ID: 24768741
[TBL] [Abstract][Full Text] [Related]
2. How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?
Volpicelli-Daley LA; Kirik D; Stoyka LE; Standaert DG; Harms AS
J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):131-155. PubMed ID: 27018978
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between alpha-synuclein and Parkinson's disease].
Nishioka K; Hattori N
Brain Nerve; 2007 Aug; 59(8):825-30. PubMed ID: 17713118
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
Olanow CW; Brundin P
Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
[TBL] [Abstract][Full Text] [Related]
5. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.
Fukusumi H; Togo K; Sumida M; Nakamori M; Obika S; Baba K; Shofuda T; Ito D; Okano H; Mochizuki H; Kanemura Y
FEBS Open Bio; 2021 Feb; 11(2):354-366. PubMed ID: 33301617
[TBL] [Abstract][Full Text] [Related]
7. Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.
Chiba-Falek O; Lopez GJ; Nussbaum RL
Mov Disord; 2006 Oct; 21(10):1703-8. PubMed ID: 16795004
[TBL] [Abstract][Full Text] [Related]
8. alpha-Synuclein gene duplication is present in sporadic Parkinson disease.
Ahn TB; Kim SY; Kim JY; Park SS; Lee DS; Min HJ; Kim YK; Kim SE; Kim JM; Kim HJ; Cho J; Jeon BS
Neurology; 2008 Jan; 70(1):43-9. PubMed ID: 17625105
[TBL] [Abstract][Full Text] [Related]
9. Genetics of Synucleinopathies.
Nussbaum RL
Cold Spring Harb Perspect Med; 2018 Jun; 8(6):. PubMed ID: 28213435
[TBL] [Abstract][Full Text] [Related]
10. Link between the SNCA gene and parkinsonism.
Xu W; Tan L; Yu JT
Neurobiol Aging; 2015 Mar; 36(3):1505-18. PubMed ID: 25554495
[TBL] [Abstract][Full Text] [Related]
11. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease.
Mizuta I; Satake W; Nakabayashi Y; Ito C; Suzuki S; Momose Y; Nagai Y; Oka A; Inoko H; Fukae J; Saito Y; Sawabe M; Murayama S; Yamamoto M; Hattori N; Murata M; Toda T
Hum Mol Genet; 2006 Apr; 15(7):1151-8. PubMed ID: 16500997
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease: from monogenic forms to genetic susceptibility factors.
Lesage S; Brice A
Hum Mol Genet; 2009 Apr; 18(R1):R48-59. PubMed ID: 19297401
[TBL] [Abstract][Full Text] [Related]
13. Threonine 53 in alpha-synuclein is conserved in long-living non-primate animals.
Larsen K; Hedegaard C; Bertelsen MF; Bendixen C
Biochem Biophys Res Commun; 2009 Sep; 387(3):602-5. PubMed ID: 19619507
[TBL] [Abstract][Full Text] [Related]
14. [Role of genetics in the etiology of synucleinopathies].
Elcoroaristizabal Martín X; Gómez Busto F; González Fernández MC; de Pancorbo MM
Rev Esp Geriatr Gerontol; 2011 Oct; 46 Suppl 1():3-11. PubMed ID: 22152908
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
Lee VM; Trojanowski JQ
Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
[TBL] [Abstract][Full Text] [Related]
16. Early-onset parkinsonism caused by alpha-synuclein gene triplication: Clinical and genetic findings in a novel family.
Olgiati S; Thomas A; Quadri M; Breedveld GJ; Graafland J; Eussen H; Douben H; de Klein A; Onofrj M; Bonifati V
Parkinsonism Relat Disord; 2015 Aug; 21(8):981-6. PubMed ID: 26077166
[TBL] [Abstract][Full Text] [Related]
17. The many faces of alpha-synuclein mutations.
Kasten M; Klein C
Mov Disord; 2013 Jun; 28(6):697-701. PubMed ID: 23674458
[TBL] [Abstract][Full Text] [Related]
18. alpha-Synuclein and Parkinson disease susceptibility.
Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C
Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362
[TBL] [Abstract][Full Text] [Related]
19. Parkinson's disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death.
Jiang H; Wu YC; Nakamura M; Liang Y; Tanaka Y; Holmes S; Dawson VL; Dawson TM; Ross CA; Smith WW
Neurobiol Aging; 2007 Nov; 28(11):1709-17. PubMed ID: 16978743
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein-based models of Parkinson's disease.
Dehay B; Fernagut PO
Rev Neurol (Paris); 2016; 172(6-7):371-8. PubMed ID: 27158042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]